These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4349527)

  • 1. Gangliosidosis with total hexosaminidase deficiency: clinical, biochemical and ultrastructural studies and comparison with conventional cases of Tay-Sachs disease.
    Fontaine G; Résibois A; Tondeur M; Jonniaux G; Farriaux JP; Voet W; Maillard E; Loeb H
    Acta Neuropathol; 1973 Jan; 23(2):118-32. PubMed ID: 4349527
    [No Abstract]   [Full Text] [Related]  

  • 2. Juvenile GM2 gangliosidosis. Biochemical and ultrastructural studies on a new variant of Tay-Sachs disease.
    Menkes JH; O'Brien JS; Okada S; Grippo J; Andrews JM; Cancilla PA
    Arch Neurol; 1971 Jul; 25(1):14-22. PubMed ID: 5146406
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1 gangliosidosis.
    Taori GM; Basu DK; Chandi S; Raman PT; Abraham J; Leelavathy R; Job CK
    J Neurol Sci; 1974 Jan; 21(1):77-92. PubMed ID: 4374511
    [No Abstract]   [Full Text] [Related]  

  • 5. The enzymology of Tay-Sachs disease and its variant forms.
    Tallman JF
    UCLA Forum Med Sci; 1975; (18):479-99. PubMed ID: 812231
    [No Abstract]   [Full Text] [Related]  

  • 6. G5-ganglioside variant of systemic late infantile lipidosis. Generalized gangliosidosis.
    Volk BW; Adachi M; Schneck L; Saifer A; Kleinberg W
    Arch Pathol; 1969 Apr; 87(4):393-403. PubMed ID: 5766766
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis).
    Suzuki K; Chen GC
    J Neuropathol Exp Neurol; 1968 Jan; 27(1):15-38. PubMed ID: 5656575
    [No Abstract]   [Full Text] [Related]  

  • 8. [GM2 gangliosidosis with total beta-N-acetyl-hexosaminidase deficit or Sandhoff's disease].
    Juif JG; Luckel JC; Nussbaum JL; Stoebner R; Kapps R
    Arch Fr Pediatr; 1973 Jan; 30(1):29-43. PubMed ID: 4721586
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of G M2 gangliosidosis of late onset.
    Buxton P; Cumings JN; Ellis RB; Lake BD; Mair WG; Roberts JR; Young EP
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):685-92. PubMed ID: 5084137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
    Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
    J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prenatal diagnosis of Sandhoff's disease (GM2-gangliosidosis, type 2)].
    Harzer K; Stengel-Rutkowski S; Gley EO; Albert A; Murken JD; Zahn V; Henkel KP
    Dtsch Med Wochenschr; 1975 Jan; 100(3):106-8. PubMed ID: 234374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular fractions from Tay-Sachs brains: ganglioside, lipid, and protein composition and hexosaminidase activities.
    Kornguth S; Wannamaker B; Kolodny E; Geison R; Scott G; O'Brien JF
    J Neurol Sci; 1974 Jul; 22(3):383-406. PubMed ID: 4857837
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease.
    Sandhoff K; Harzer K; Wässle W; Jatzkewitz H
    J Neurochem; 1971 Dec; 18(12):2469-89. PubMed ID: 5135907
    [No Abstract]   [Full Text] [Related]  

  • 14. Juvenile GM2-gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease.
    Suzuki K; Rapin I; Suzuki Y; Ishii N
    Neurology; 1970 Feb; 20(2):190-204. PubMed ID: 5460705
    [No Abstract]   [Full Text] [Related]  

  • 15. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
    Schneck L; Amsterdam D; Brooks SE; Rosenthal AL; Volk BW
    Pediatrics; 1973 Aug; 52(2):221-6. PubMed ID: 4721444
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tay-Sachs disease].
    Okada S
    Nihon Rinsho; 1973 Aug; 31(8):2463-8. PubMed ID: 4588056
    [No Abstract]   [Full Text] [Related]  

  • 17. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical juvenile neurolipidosis. Ultrastructural study of a cerebral biopsy].
    Pellissier JF; O'Croinin P; Hassoun J; Roger J; Suzuki K; Toga M
    J Neurol Sci; 1975 Jun; 25(2):183-96. PubMed ID: 168323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catabolism of Tay-Sachs ganglioside in rat brain lysosomes.
    Tallman JF; Brady RO
    J Biol Chem; 1972 Dec; 247(23):7570-5. PubMed ID: 4636324
    [No Abstract]   [Full Text] [Related]  

  • 20. The fetal aspects of Tay-Sachs disease.
    Schneck L; Adachi M; Volk BW
    Pediatrics; 1972 Mar; 49(3):342-51. PubMed ID: 4334559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.